Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
The COVID Boom: CBER Receives More INDs in One Quarter Than The Previous 30 Combined
Apr 08 2021
•
By
Derrick Gingery
CBER continued to see INDs for cell and gene therapies, in addition to COVID-19 countermeasures, in recent months. • Source: Alamy
More from United States
More from North America